COMP <GO>
BDX vs RMD // GROSS PROFIT MARGIN
Becton Dickinson and Company (NYSE) VS. ResMed Inc. (NYSE) • 15-METRIC TALLY: BDX 4
— RMD 10
▲ GROSS PROFIT MARGIN LEADER: RMD
LAST: $197.88 (-0.23%) • MKT CAP: $54.03B
gross-margins
45.40%
LAST: $229.94 (-9.05%) • MKT CAP: $35.56B
gross-margins
59.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDX VS. RMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDX | RMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 45.40% | 59.40% | -14.00 | RMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 22.90% | -18.00 | RMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 19.9x | +1.90 | RMD | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 4.67% | -2.54 | RMD | /fcf-yield <GO> |
| Operating Margin | 11.80% | 32.70% | -20.90 | RMD | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 27.20% | -19.50 | RMD | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 9.80% | -1.60 | RMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.21% | 0.87% | +1.34 | BDX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 12.49 | -10.27 | RMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | RMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.6 | 60.1 | +4.50 | BDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.93 | +0.13 | BDX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.9x | 23.6x | +6.30 | RMD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.03B | $35.56B | $18.47B | BDX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDX REV | RMD REV | BDX GROSS % | RMD GROSS % | BDX FCF | RMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.84B | $5.15B | 45.4% | 59.4% | — | $1.66B |
| FY 2024 | $20.18B | $4.69B | 45.2% | 56.7% | — | $1.30B |
| FY 2023 | $19.37B | $4.22B | — | — | — | $503.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDX // BETA 1.06
RMD // BETA 0.93